AI Article Synopsis
- Testicular cancer is the most common cancer in men aged 15-34, with an average 5-year survival rate of 85% after treatment.
- A 34-year-old man, previously treated for right testicle cancer, experienced pain in his left testicle and was found to have raised tumour markers, indicating a new cancer.
- 1-3% of testicular cancer patients may develop a separate cancer in the other testicle later, highlighting the importance of follow-up and self-examination for early detection.
Article Abstract
Background: In men aged 15-34 testicular cancer is the most commonly occurring malignancy. After treatment, the average 5-year survival rate is 85%. Recurring symptoms or raised tumour markers may indicate the presence of a second primary contralateral testicular tumour.
Case Description: A 34-year-old man presented with pain in his left testicle. Eight years previously he had been diagnosed with cancer of his right testicle which was treated successfully by orchidectomy and two cycles of chemotherapy. Further investigations revealed raised tumour markers. The patient proved to have a contralateral testis carcinoma with 2 lung metastases.
Conclusion: 1-3% of patients with testicular cancer develop metachronous (i.e. not concurrent) contralateral testicular cancer. Follow-up and self-examination are very important for early diagnosis of a metachronous contralateral malignancy.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!